Transaction · 0001562180-25-000111

MAHON PAUL A

MAHON PAUL A, EVP, GC, reported a transaction classified as return at UNITED THERAPEUTICS Corp involving 7700.000000 shares for an estimated $2773694.00. Reported holdings after the transaction were 36710.000000 shares. The stored filing text includes a detected 10b5-1 reference.

returnSEC transaction code DEVP, GC
UTHRUNITED THERAPEUTICS Corp
Filing timeJan 03
Trade dateJan 02, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

UTHR price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
UTHR since 2025-01-03Filed 609 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
return
Code D
Identifier
0001562180-25-000111
Common Stock
Transaction date
Jan 02, 2025
Filed Jan 03, 2025, 09:30 PM · 1d delay
Shares
7.70k sh
$36.0k per share
Estimated value
-$277M
Computed from shares × price
Holdings after
36.7k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP & GENERAL COUNSEL

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    This is an exercise of share tracking awards pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on June 20, 2024. Share tracking awards are non-dilutive cash-settled stock app…

  2. converted into shares of common stock.

  3. F2

    Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Original filing · 0001562180-25-000111
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

UTHR